{"id":"https://openalex.org/W4388973027","doi":"https://doi.org/10.1097/moh.0000000000000796","title":"The future of HOXA-expressing leukemias: Menin inhibitor response and resistance","display_name":"The future of HOXA-expressing leukemias: Menin inhibitor response and resistance","publication_year":2023,"publication_date":"2023-11-23","ids":{"openalex":"https://openalex.org/W4388973027","doi":"https://doi.org/10.1097/moh.0000000000000796","pmid":"https://pubmed.ncbi.nlm.nih.gov/38010951"},"language":"en","primary_location":{"id":"doi:10.1097/moh.0000000000000796","doi":"https://doi.org/10.1097/moh.0000000000000796","is_oa":false,"landing_page_url":"https://doi.org/10.1097/moh.0000000000000796","pdf_url":null,"source":{"id":"https://openalex.org/S15004046","display_name":"Current Opinion in Hematology","issn_l":"1065-6251","issn":["1065-6251","1080-8213","1531-7048"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Hematology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014885323","display_name":"Daniela Vanessa Wenge","orcid":"https://orcid.org/0000-0002-0064-9104","observed_orcids":["https://orcid.org/0000-0002-0064-9104"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniela V. Wenge","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012956545","display_name":"Scott A. Armstrong","orcid":"https://orcid.org/0000-0002-9099-4728","observed_orcids":["https://orcid.org/0000-0002-9099-4728"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Scott A. Armstrong","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA","to Scott A. Armstrong, 360 Longwood Avenue, LC-8201, Boston, MA 02215, USA. Tel: +1 617 632 2991; fax: +1 617 632 5710; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: +1 617 632 5710","to Scott A. Armstrong, 360 Longwood Avenue, LC-8201, Boston, MA 02215, USA. Tel: +1 617 632 2991"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"to Scott A. Armstrong, 360 Longwood Avenue, LC-8201, Boston, MA 02215, USA. Tel: +1 617 632 2991; fax: +1 617 632 5710; e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 632 5710","institution_ids":[]},{"raw_affiliation_string":"to Scott A. Armstrong, 360 Longwood Avenue, LC-8201, Boston, MA 02215, USA. Tel: +1 617 632 2991","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5012956545"],"corresponding_institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":1.0161,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.71849427,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"31","issue":"2","first_page":"64","last_page":"70"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.028999999165534973,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.014800000004470348,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/menin-inhibitors","display_name":"menin inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/hoxa-cluster","display_name":"HOXA cluster","score":0.621999979019165},{"id":"https://openalex.org/keywords/acute-leukemia","display_name":"acute leukemia","score":0.8560000061988831},{"id":"https://openalex.org/keywords/mll-rearrangement","display_name":"MLL rearrangement","score":0.9399999976158142},{"id":"https://openalex.org/keywords/npm1-mutation","display_name":"NPM1 mutation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7490000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5775547027587891},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5545425415039062},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5161370038986206},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49386292695999146},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.37767404317855835},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35893678665161133},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3021664023399353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24934852123260498},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.20585224032402039}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011495","descriptor_name":"Histone-Lysine N-Methyltransferase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051788","descriptor_name":"Myeloid-Lymphoid Leukemia Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051788","descriptor_name":"Myeloid-Lymphoid Leukemia Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/moh.0000000000000796","doi":"https://doi.org/10.1097/moh.0000000000000796","is_oa":false,"landing_page_url":"https://doi.org/10.1097/moh.0000000000000796","pdf_url":null,"source":{"id":"https://openalex.org/S15004046","display_name":"Current Opinion in Hematology","issn_l":"1065-6251","issn":["1065-6251","1080-8213","1531-7048"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Hematology","raw_type":"journal-article"},{"id":"pmid:38010951","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38010951","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in hematology","raw_type":"Review"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3052913179","display_name":"Targeting DOT1L for Degradation in MLL-rearranged Leukemia","funder_award_id":"R01CA176745","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4933731489","display_name":"SPORE in Multiple Myeloma","funder_award_id":"P50CA100707","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5786819219","display_name":"Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies","funder_award_id":"R01CA204639","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000889887","display_name":"Development of Novel Therapeutic Strategies in Human Leukemias","funder_award_id":"P01CA066996","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W1605195795","https://openalex.org/W1607484210","https://openalex.org/W1968048144","https://openalex.org/W1973007669","https://openalex.org/W1982113493","https://openalex.org/W1982315838","https://openalex.org/W1990739246","https://openalex.org/W2011152373","https://openalex.org/W2046540572","https://openalex.org/W2061881437","https://openalex.org/W2069591815","https://openalex.org/W2077530603","https://openalex.org/W2082592723","https://openalex.org/W2090977067","https://openalex.org/W2109363337","https://openalex.org/W2151718828","https://openalex.org/W2154218976","https://openalex.org/W2170515966","https://openalex.org/W2328701990","https://openalex.org/W2419140434","https://openalex.org/W2553171682","https://openalex.org/W2554624179","https://openalex.org/W2773514102","https://openalex.org/W2890477656","https://openalex.org/W2913532930","https://openalex.org/W2983865835","https://openalex.org/W2993435749","https://openalex.org/W3001120382","https://openalex.org/W3004043543","https://openalex.org/W3037271455","https://openalex.org/W3038382610","https://openalex.org/W3042129338","https://openalex.org/W3092458827","https://openalex.org/W3167620265","https://openalex.org/W3204213484","https://openalex.org/W3214531230","https://openalex.org/W4205640844","https://openalex.org/W4214571245","https://openalex.org/W4220698374","https://openalex.org/W4229459984","https://openalex.org/W4241093998","https://openalex.org/W4246697467","https://openalex.org/W4283271244","https://openalex.org/W4283324313","https://openalex.org/W4284884567","https://openalex.org/W4310102698","https://openalex.org/W4310107876","https://openalex.org/W4310119326","https://openalex.org/W4310120232","https://openalex.org/W4310597699","https://openalex.org/W4310602693","https://openalex.org/W4322008191","https://openalex.org/W4324330071","https://openalex.org/W4324344184","https://openalex.org/W4362592299","https://openalex.org/W4362638831","https://openalex.org/W4365453495","https://openalex.org/W4367173815","https://openalex.org/W4385665958","https://openalex.org/W4385702177","https://openalex.org/W6701892803","https://openalex.org/W6851805994"],"related_works":["https://openalex.org/W4414162767","https://openalex.org/W7153108946","https://openalex.org/W4396702093","https://openalex.org/W4412001415","https://openalex.org/W4393867324","https://openalex.org/W7204215927","https://openalex.org/W4414751685","https://openalex.org/W7124968013","https://openalex.org/W7147516554","https://openalex.org/W7163527832"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"We":[3],"provide":[4],"an":[5,169],"update":[6],"on":[7,62,156],"the":[8,21,66,149,174,186],"successes":[9],"and":[10,90,141,182],"ongoing":[11],"challenges":[12],"of":[13,23,68,94,118,129,188,191],"Menin":[14,77,101,121,166],"inhibition":[15],"as":[16,78,115],"a":[17,59,79,116],"novel":[18],"approach":[19],"for":[20,159],"treatment":[22,157],"patients":[24,53,160],"with":[25,35],"acute":[26],"leukemias":[27,34,162],"that":[28,71],"express":[29],"HOXA":[30],"cluster":[31],"genes":[32],"including":[33],"KMT2A":[36],"-rearrangements,":[37],"NPM1":[38],"mutations":[39,70,110],"or":[40],"NUP98":[41],"-rearrangements.":[42],"Initial":[43],"clinical":[44,96,106,145,171,179],"trials":[45],"show":[46],"promising":[47],"response":[48,152],"rates":[49],"in":[50,82,127,138,142],"heavily":[51],"pretreated":[52],"suggesting":[54],"these":[55,130],"inhibitors":[56,167],"may":[57],"have":[58,104,111],"significant":[60],"impact":[61],"patient":[63],"outcome.":[64],"Furthermore,":[65],"development":[67,187],"resistance":[69,119,124,164,189],"decrease":[72],"drug":[73],"binding":[74],"affinity,":[75],"validates":[76],"therapeutic":[80],"target":[81],"human":[83],"cancers.":[84],"Therapeutic":[85],"strategies":[86],"aiming":[87],"at":[88],"overcoming":[89],"preventing":[91],"resistance,":[92],"are":[93,134],"high":[95],"relevance.":[97],"RECENT":[98],"FINDINGS:":[99],"Several":[100],"inhibitor":[102],"chemotypes":[103],"entered":[105],"trials.":[107,146],"Acquired":[108],"point":[109],"recently":[112],"been":[113],"described":[114],"mechanism":[117],"towards":[120],"inhibitors.":[122],"However,":[123],"can":[125],"develop":[126,163],"absence":[128],"mutations.":[131],"Combination":[132],"therapies":[133],"currently":[135],"being":[136],"investigated":[137],"preclinical":[139],"models":[140],"early":[143],"phase":[144],"SUMMARY:":[147],"Given":[148],"remarkable":[150],"overall":[151],"rates,":[153],"shedding":[154],"light":[155],"options":[158],"whose":[161],"to":[165,177,183],"is":[168,190],"imminent":[170],"need.":[172],"Studying":[173],"underlying":[175],"mechanisms":[176],"inform":[178],"decision":[180],"making,":[181],"potentially":[184],"prevent":[185],"outmost":[192],"importance.":[193]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-11-25T00:00:00"}